Breaking News Headlines Today

News about Gilead Sciences

Stay current with all the latest and breaking news about Gilead Sciences, compare headlines and perspectives between news sources on stories happening today. In total, 44 stories have been published about Gilead Sciences which Ground News has aggregated in the past 3 months.

Covered Most By

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Best Pharmaceutical Stocks To Watch Now - October 22nd

100% Center coverage: 1 sources

Eli Lilly and Company, Pfizer, Avadel Pharmaceuticals, Novo Nordisk A/S, Abbott Laboratories, Gilead Sciences, and AbbVie are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies involved in reseStock Markets Read Article

Health Canada approves Gilead Sciences’ Lyvdelzi for PBC

Health Canada has granted conditional approval for Gilead Sciences’ Lyvdelzi for PBC patients who have difficulty with standard treatment.Health Canada · Canada Read Article

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, BMO Capital Markets Analyst Says

100% Center coverage: 1 sources

BMO Capital Markets lifted their price target on Gilead Sciences from $130.00 to $135.00 and gave the stock an "outperform" rating in a report on Monday.Stock Markets Read Article

Raheem DeVaughn announces "20 Lessons of Love Tour"

(New York, NY. – October 17th, 2025) — Grammy Awarded singer, songwriter, host of WHUR’s 96.3 Original Quiet Storm, philanthropist and self-proclaimed “Love King,” Raheem DeVaughn, is set to bring his soulful blend of R&B and conscious artistry to audiences nationwide with the announcement of his “20 Lessons of Love Tour”, supported by Gilead Sciences. Launched on October 12, 2025, in Honolulu, HI. the 20 Lessons of Love Tour will make its way a…Grammy Awards · New York See the Story

Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years - Gilead Sciences (NASDAQ:GILD)

100% Center coverage: 1 sources

Gilead Sciences Read Article

2 Surefire Dividend Stocks to Buy for the Long Haul @themotleyfool #stocks $NVS $GILD

100% Left coverage: 1 sources

Key PointsNovartis and Gilead Sciences have businesses that can perform well during downturns.Novartis has an extensive portfolio of medicines across many therapeutic areas.Gilead Sciences leads the HIV market and is expanding its oncology lineup. 10 stocks we like better than Novartis › Equity markets experienced significant volatility this year. Many investors feared that President Donald Trump's aggressive trade policies would plunge the econ…Gilead Sciences · United States Read Article

Is Gilead Sciences Inc Gaining or Losing Market Support? - Gilead Sciences (NASDAQ:GILD)

100% Center coverage: 1 sources

Gilead Sciences · Foster City Read Article

Uganda: Cheaper HIV Prevention Drug Coming

100% Center coverage: 2 sources

[Independent (Kampala)] Kampala -- THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between producers and key HIV/AIDS prevention programme advocates.Gilead Sciences · Brazil See the Story

Novartis and Linde vs. Glaxosmithkline and Medigene – Commented Kw 39 Peer Group Watch Pharma, Chemistry, Biotech, Medicine & Health

James Uthmeier Says Pharma Company Ordered to Pay Florida $3M in HIV Drug Kickback Lawsuit

100% Center coverage: 1 sources

Attorney General James Uthmeier announced Wednesday that a multimillion-dollar settlement has been reached with a pharmaceutical company accused of paying kickbacks to health providers involved with a drug used to treat HIV and AIDS patients. The company, Gilead Sciences Inc., was sued by Florida and several other states for allegedly requiring health care providers to promote its drugs in exchange for compensation. The HIV drugs included Stribi…Gilead Sciences · Florida See the Story

News about Gilead Sciences

News about Gilead Sciences

Covered Most By

Local News Publishers

Best Pharmaceutical Stocks To Watch Now - October 22nd

Health Canada approves Gilead Sciences’ Lyvdelzi for PBC

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, BMO Capital Markets Analyst Says

Raheem DeVaughn announces "20 Lessons of Love Tour"

Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years - Gilead Sciences (NASDAQ:GILD)

2 Surefire Dividend Stocks to Buy for the Long Haul @themotleyfool #stocks $NVS $GILD

Is Gilead Sciences Inc Gaining or Losing Market Support? - Gilead Sciences (NASDAQ:GILD)

Uganda: Cheaper HIV Prevention Drug Coming

Novartis and Linde vs. Glaxosmithkline and Medigene – Commented Kw 39 Peer Group Watch Pharma, Chemistry, Biotech, Medicine & Health

James Uthmeier Says Pharma Company Ordered to Pay Florida $3M in HIV Drug Kickback Lawsuit

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Gilead Sciences

Best Pharmaceutical Stocks To Watch Now - October 22nd

Health Canada approves Gilead Sciences’ Lyvdelzi for PBC

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, BMO Capital Markets Analyst Says

Raheem DeVaughn announces "20 Lessons of Love Tour"

Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years - Gilead Sciences (NASDAQ:GILD)

2 Surefire Dividend Stocks to Buy for the Long Haul @themotleyfool #stocks $NVS $GILD

Is Gilead Sciences Inc Gaining or Losing Market Support? - Gilead Sciences (NASDAQ:GILD)

Uganda: Cheaper HIV Prevention Drug Coming

Novartis and Linde vs. Glaxosmithkline and Medigene – Commented Kw 39 Peer Group Watch Pharma, Chemistry, Biotech, Medicine & Health

James Uthmeier Says Pharma Company Ordered to Pay Florida $3M in HIV Drug Kickback Lawsuit